Ray Co., Ltd. (228670.KQ)

KRW 8520.0

(4.41%)

Revenue Summary of Ray Co., Ltd.

Ray Co., Ltd.'s latest annual revenue in 2023 was 145.88 Billion KRW , up 13.09% from previous year.
Ray Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 24.74 Billion KRW , up 42.47% from previous quarter.
Ray Co., Ltd. reported a annual revenue of 128.99 Billion KRW in annual revenue 2022, up 42.8% from previous year.
Ray Co., Ltd. reported a annual revenue of 90.33 Billion KRW in annual revenue 2021, up 63.64% from previous year.
Ray Co., Ltd. reported a quarterly revenue of 24.74 Billion KRW for 2024 Q2, up 42.47% from previous quarter.
Ray Co., Ltd. reported a quarterly revenue of 38.53 Billion KRW for 2023 Q3, down -2.08% from previous quarter.

Annual Revenue Chart of Ray Co., Ltd. (2023 - 2017)

Historical Annual Revenue of Ray Co., Ltd. (2023 - 2017)

Year	Revenue	Revenue Growth
2023	145.88 Billion KRW	13.09%
2022	128.99 Billion KRW	42.8%
2021	90.33 Billion KRW	63.64%
2020	55.2 Billion KRW	-24.49%
2019	73.1 Billion KRW	41.87%
2018	51.53 Billion KRW	56.5%
2017	32.92 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q1	17.36 Billion KRW	-63.79%
2024 Q2	24.74 Billion KRW	42.47%
2023 Q3	38.53 Billion KRW	-2.08%
2023 Q4	47.96 Billion KRW	24.46%
2023 FY	145.88 Billion KRW	13.09%
2023 Q2	39.35 Billion KRW	96.55%
2023 Q1	20.02 Billion KRW	-57.6%
2022 Q2	31.16 Billion KRW	76.8%
2022 FY	128.99 Billion KRW	42.8%
2022 Q4	47.22 Billion KRW	43.17%
2022 Q3	32.98 Billion KRW	5.85%
2022 Q1	17.62 Billion KRW	-33.7%
2021 FY	90.33 Billion KRW	63.64%
2021 Q4	26.58 Billion KRW	5.65%
2021 Q3	25.16 Billion KRW	0.0%
2020 FY	55.2 Billion KRW	-24.49%
2019 FY	73.1 Billion KRW	41.87%
2018 FY	51.53 Billion KRW	56.5%
2017 FY	32.92 Billion KRW	0.0%

Peer Revenue Comparison of Ray Co., Ltd.

Name	Revenue	Revenue Difference
Osang Healthcare Co.,Ltd	355.84 Billion KRW	59.004%
InBody Co.,Ltd	170.35 Billion KRW	14.364%
Curexo Inc.	72.88 Billion KRW	-100.161%
Seegene, Inc.	367.37 Billion KRW	60.291%
i-SENS, Inc.	265.12 Billion KRW	44.975%
Gencurix Inc.	2.6 Billion KRW	-5510.156%
Sugentech Inc.	7.13 Billion KRW	-1945.368%
L&C Bio Co., Ltd	68.86 Billion KRW	-111.823%